Ordered mesoporous materials for drug delivery applications

dc.contributor.authorSimovic, S.
dc.contributor.authorLosic, D.
dc.contributor.editorJenkins, S.
dc.date.issued2010
dc.description.abstractConventional drug therapy is associated with a number of challenges, such as poor drug stability and/or solubility in biological environment, lack of selectivity, severe toxicity and unfavourable pharmacokinetics. The application of nanotechnology to medical devices - "nanomedicine" is recognized as an emerging field with huge potential for development of new therapeutic concepts. Research on mesoporous materials for biomedical purposes has experienced an outstanding increase during recent years. Three major types of mesoporous materials for drug delivery application were emerged including: mesoporous silica engineered by organic synthesis and porous silicon, anodically oxidised alumina (AAO) and nanotubular titania fabricated by electrochemical methods. Although still in early stages, few in vivo studies clearly show the potential of these materials for drug delivery devices in orthopedics implants, dental implants, and vascular stents, where not only is the controlled release of drugs such as antibiotics or growth factors desired, but also appropriate biointegration is needed. In this chapter we collect and analyze some of the most relevant milestones in the research of mesoporous materials for controlled drug delivery for implantable and systemic delivery systems. To provide a comprehensive overview to the reader, this review firstly analyzes biocompatibility aspects, which are the major prerequisite for application of materials that come into contact with biological systems. Secondly, we consider the basic aspects of the textural properties (surface and porosity) that contribute to the understanding of drug adsorption and controlled release processes. Finally, more sophisticated stimuli-responsive materials are reviewed. This is only beginning of the further research in terms of correlating biomaterial chemistry and tissue responses and new clinical approaches required not only for orthopaedics, but also treatment for a number of other diseases (hearth, cancer, diabetes, Parkinson's, Alzheimer's etc)
dc.description.statementofresponsibilitySpomenka Simovic and Dusan Losic
dc.identifier.citationNanoporous materials: types, properties, and uses, 2010 / Jenkins, S. (ed./s), Ch.3, pp.73-162
dc.identifier.isbn9781616681821
dc.identifier.orcidLosic, D. [0000-0002-1930-072X]
dc.identifier.urihttp://hdl.handle.net/2440/84935
dc.language.isoen
dc.publisherNova Science Publishers
dc.publisher.placeUSA
dc.relation.ispartofseriesNanotechnology Science and Technology
dc.rightsCopyright 2010 Nova Science Publishers
dc.source.urihttps://search.ebscohost.com/login.aspx?custid=s3684833%26authtype=shib%26direct=true%26authtype=ip%26db=nlebk%26AN=341659%26site=ehost-live%26ebv=EB%26ppid=pp_73
dc.subjectdrug delivery
dc.subjectmesproous materials
dc.subjectporous alumina
dc.subjectporous silica
dc.titleOrdered mesoporous materials for drug delivery applications
dc.typeBook chapter
pubs.publication-statusPublished

Files